- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biosyent Inc. (RX)
Track today's live Biosyent Inc. (RX) share price, performance and key data on this page with our current TSXV:RX stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Biosyent Inc. share price on the TSXV exchange. Use the dropdown to switch exchange for the RX share price, head to our technical summary section, which provides analysis on Biosyent Inc. share price buy/sell indicators using real-time data (or discuss the Biosyent Inc. (RX) stock price today with other investors in the Biosyent Inc. TSXV share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TSXV:RX share price (ISIN: CA0906901081) to enhance your trading decisions with our free investment tools and resources.
What Is the Biosyent Inc. Share Price Today?
The Biosyent Inc. share price today is 15.00.
What Is the Stock Symbol for Biosyent Inc.
The stock symbol (or 'ticker') for Biosyent Inc. is "RX."
What Stock Exchange Does Biosyent Inc. Trade On?
Biosyent Inc. is listed and trades on the TSXV stock exchange.
Is Biosyent Inc. a Good Stock to Buy?
Determining whether Biosyent Inc. (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current TSXV:RX share price (ISIN: CA0906901081) to enhance your trading decisions with our free investment tools and resources.
What Is the Biosyent Inc. Share Price Today?
The Biosyent Inc. share price today is 15.00.
What Is the Stock Symbol for Biosyent Inc.
The stock symbol (or 'ticker') for Biosyent Inc. is "RX."
What Stock Exchange Does Biosyent Inc. Trade On?
Biosyent Inc. is listed and trades on the TSXV stock exchange.
Is Biosyent Inc. a Good Stock to Buy?
Determining whether Biosyent Inc. (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
15.00
-0.49(-3.16%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.99
15.50
52 wk Range
10.65
15.80
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.9915.50
52 wk Range
10.6515.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.47%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.47%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
18.00
Upside
+20.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.00
(+20.00% Upside)
Biosyent Inc. Earnings Call Summary for Q1/2026
- BioSyent reported Q1 2026 revenue of CAD 13.9M, up 27% YoY; EPS held steady at CAD 0.20 despite stock declining 0.82% to CAD 14.55.
- Oral Science acquisition added CAD 3.0M in March sales; Canadian pharmaceutical sales grew 9% while international sales faced headwinds.
- Company maintained 63 consecutive profitable quarters with EBITDA rising 14% to CAD 3.6M and net income up 1% to CAD 2.345M.
- Management projects Q2 2026 EPS of CAD 0.21 and Q3 EPS of CAD 0.22, with revenues expected at CAD 12.9M and CAD 13.63M respectively.
- CEO cited successful Oral Science integration; plans international expansion of oral health portfolio amid risks from geopolitical tensions and tariffs.
Last Updated: 14/05/2026, 23:26
Read Full TranscriptEarnings
Latest Release
14/05/2026
EPS / Forecast
0.20 / --
Revenue / Forecast
13.91M / --
Compare RX to Peers and Sector
Metrics to compare | RX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.0x | −3.5x | −0.4x | |
PEG Ratio | 1.08 | 0.03 | 0.00 | |
Price/Book | 3.8x | 0.5x | 2.6x | |
Price / LTM Sales | 3.7x | 0.8x | 3.0x | |
Upside (Analyst Target) | 20.0% | 121.6% | 48.7% | |
Fair Value Upside | Unlock | 7.8% | 5.6% | Unlock |
BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. BioSyent Inc. was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. The company was incorporated in 2006 and is headquartered in Mississauga, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Biosyent Inc. (TSXV: RX) Share Price Today?
The Biosyent Inc. stock price today is 15.00 CAD.
What Stock Exchange Does Biosyent Inc. (RX) Trade On?
Biosyent Inc. is listed and trades on the TSX Venture Exchange.
What Is the Ticker (Stock Symbol) for Biosyent Inc.?
The stock symbol (also called a 'ticker') for Biosyent Inc. is "RX."
Does Biosyent Inc. Pay Dividends? What’s The Current RX Dividend Yield?
Yes, RX Pays Dividends to its Shareholders. The current Biosyent Inc. dividend yield is 1.47%.
What Is the Current Biosyent Inc. Market Capitalisation?
As of today, Biosyent Inc. (TSXV: RX) market cap is 177.18M CAD.
What Is Biosyent Inc.'s (RX) Earnings Per Share (TTM)?
The Biosyent Inc. EPS is currently 0.78 (Trailing Twelve Months).
When Is the Next Biosyent Inc. Earnings Date?
Biosyent Inc.'s next earnings report will be released on 25/08/2026.
Is RX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Biosyent Inc. moving averages and other technical indicators, the daily buy/sell signal for RX stock is Strong Buy.
How Many Times Has Biosyent Inc. Stock Split?
Biosyent Inc. has split 0 times. (See the RX stock split history page for full effective split date and price information.)
What is the current trading status of Biosyent Inc. (TSXV: RX)?
As of 08/08/2026, Biosyent Inc. (RX) is trading at a share price of 15.00 CAD, with a previous close of 15.49 CAD. The stock has fluctuated within a day range of 14.99 CAD to 15.50 CAD, while its 52-week range spans from 10.65 CAD to 15.80 CAD.
What Is Biosyent Inc. (RX) Price Target According to Analysts?
The average 12-month price target for Biosyent Inc. is 18.00 CAD, with a high estimate of 18 CAD and a low estimate of 18 CAD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +20.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.